SLC31A2 and cancer: Galleggiante et al. [49] described and characterized a population of resident CD133+/CD24+/CTR2+ cancer stem cells in patients with ccRCC, nevertheless CD133+/CD24+ cells exist both in tubular adult renal progenitor cell and RCC derived cells.